sp94 peptide SP94 peptide-modified nanoparticles demonstrated 10,000-fold greater affinity - pro-collagen-peptide-firming-eye-serum selectively targets liver cancer cells SP94 Peptide: A Targeted Approach to Hepatocellular Carcinoma

viral-peptides The SP94 peptide has emerged as a significant tool in the ongoing research and therapeutic development for hepatocellular carcinoma (HCC), commonly known as liver cancerTargeting Hepatic Cancer Cells with PEGylated Dendrimers .... This peptide demonstrates a remarkable high specificity for hepatocellular carcinoma cells, making it a valuable ligand for targeted drug delivery systems and diagnostic probes. Research consistently highlights SP94's ability to selectively bind to HCC cells, often with significantly greater affinity compared to normal hepatic or endothelial cells, thereby offering a promising avenue for more effective and less toxic cancer treatments.

The development and investigation of SP94 peptide stem from the need for precise targeting in oncology. Traditional cancer therapies, such as chemotherapy, often affect healthy cells alongside cancerous ones, leading to undesirable side effects. Targeted therapies, however, aim to deliver therapeutic agents directly to the tumor site, minimizing collateral damage. SP94, identified through methods like phage display technology, fulfills this role by acting as a molecular beacon that recognizes and attaches to the specific surface markers present on HCC cells. Its sequence, often represented as SFSIIHTPILPL, is the key to this selective recognition.

SP94 Peptide in Drug Delivery Systems

A primary application of the SP94 peptide is its conjugation to various nanocarrier systems for enhanced drug delivery. By decorating nanoparticles, liposomes, or even protein-based carriers like human H-chain ferritin with SP94, researchers aim to create "smart" therapeutic agents. These SP94 peptide-modified nanoparticles can then actively seek out and bind to liver tumors. For instance, studies have explored SP94-functionalized polymersomal doxorubicin hydrochloride (SP94-PS-DOX) and SP94-modified nanoparticles that demonstrated a 10,000-fold greater affinity for HCC cells than for normal tissues. This enhanced targeting significantly improves the concentration of the therapeutic payload at the tumor site, potentially increasing efficacy and reducing systemic toxicity.

Furthermore, SP94 has been integrated into dual-peptide systems, such as dual-peptide (SP94/TAT) co-modified liposomes.作者：J Zhang·2021·被引用次数：20—SP94 peptide-modified nanoparticles demonstrated 10,000-fold greater affinitytoward HCC cells than toward normal hepatic cells and endothelial cells [34]. SP94 ... The combination of SP94 for HCC targeting and other peptides like TAT (a cell-penetrating peptide) can further optimize drug delivery by facilitating cellular uptake after the SP94 has bound to the tumor cellSP94-lactosyl links hepatocellular carcinoma-targeting peptides to lactosethrough cysteine sulfhydryl groups or lysine ε-amino residues. Supplier, CD BioGlyco.. The ability to link SP94 to carriers via specific chemical modifications, such as through cysteine conjugation (SP94 peptide, Cys conjugated), allows for stable and controlled attachment, crucial for the integrity and function of the drug delivery system.

Applications in Therapy and Diagnostics

Beyond drug delivery, the SP94 peptide's specific binding capabilities also lend themselves to diagnostic applications and advanced therapeutic strategies like chemo/sonodynamic therapy. Its precise interaction with HCC cells makes it a potential probe for early detection or monitoring of tumor progression. In therapeutic contexts, SP94-directed chemo/sonodynamic therapy aims to combine the targeted delivery of chemotherapeutic agents with other modalities to enhance tumor destruction.SP94 peptide For example, SP94 peptide-directed chemo/sonodynamic therapy for liver cancer has been investigated using oxygen self-enriched nanovesicles, where SP94 guides the nanovesicles to the tumor, improving the selectivity and efficacy of the combined treatment.SP94 peptide, Cys conjugated,is a liver cancer (HCC) targeting peptide linked with Cys. It is applicable in synthesizing stimulus-responsive peptide ...

The investigation of SP94 as a specific probe for hepatocellular carcinoma cells is a testament to its potentialDSPE-PEG2000-Mal-CLPLIPTHIISFS. Its ability to home specifically to tumor tissues in vivo, while showing minimal binding to normal visceral organs, underscores its safety profile for targeted applications. This specificity is paramount for developing treatments that are not only effective but also well-tolerated by patients.

Future Directions and Considerations

While the SP94 peptide shows immense promise, ongoing research continues to refine its applications. Studies are exploring its use in conjunction with various nanocarriers, including PEGylated dendrimers and genetically engineered virus-like particles, to optimize targeting and payload delivery. The precise sequence and modifications of SP94 can influence its binding affinity and efficacy, leading to the development of various forms, such as SP94-lactosyl or SP94 peptide, Cys conjugated, each tailored for specific delivery mechanisms or therapeutic goals.

The journey from peptide discovery to clinical application involves rigorous preclinical verification and validation. Research into SP-94-peptide and similar targeted agents aims to confirm their efficacy in treating hepatoma xenografts and other liver cancer models.Peptides and Cancer Concerns: What You Should Know Before Starting ... As the understanding of HCC biology deepens, the SP94 peptide stands out as a critical component in the development of next-generation targeted therapies, offering hope for improved outcomes for patients battling this challenging disease.